Target
Capsid protein
Ligand
BDBM400130
Substrate
n/a
Meas. Tech.
HBV DNA Quantification Assay
EC50
29.9±n/a nM
Citation
 Du, JKaplan, JAKirschberg, TAKobayashi, TLazerwith, SELee, RAMedley, JWMitchell, MLMorganelli, PAPyun, HShevick, SLSquires, NHWatkins, WJ Substituted pyrrolizine compounds and uses thereof US Patent  US10874640 Publication Date 12/29/2020 
Target
Name:
Capsid protein
Synonyms:
C | CAPSD_HBVCJ | Core antigen | Core protein | HBcAg | p21.5
Type:
Enzyme Catalytic Domain
Mol. Mass.:
21105.01
Organism:
Hepatitis B virus genotype C subtype ayr (isolate Human/Japan/Okamoto/-) (HBV-C)
Description:
n/a
Residue:
183
Sequence:
MDIDPYKEFGASVELLSFLPSDFFPSIRDLLDTASALYREALESPEHCSPHHTALRQAILCWGELMNLATWVGSNLEDPASRELVVSYVNVNMGLKIRQLLWFHISCLTFGRETVLEYLVSFGVWIRTPPAYRPPNAPILSTLPETTVVRRRGRSPRRRTPSPRRRRSQSPRRRRSQSRESQC
  
Inhibitor
Name:
BDBM400130
Synonyms:
N-(3-chloro-4-fluorophenyl)-7-(2-((3-cyanobicyclo[1.1.1]pentan-1-yl)amino)-2-oxoacetyl)-6-methyl-2,3-dihydro-1H-pyrrolizine-5-carboxamide | US10328053, Compound 112 | US10874640, Compound 112 | US20230270719, Compound 112
Type:
Small organic molecule
Emp. Form.:
C23H20ClFN4O3
Mol. Mass.:
454.881
SMILES:
Cc1c(C(=O)C(=O)NC23CC(C2)(C3)C#N)c2CCCn2c1C(=O)Nc1ccc(F)c(Cl)c1
Structure:
Search PDB for entries with ligand similarity: